curl --request GET \
  --url https://api.pav.bio/v1/fda/applications/{application_key} \
  --header 'Authorization: Bearer <token>'

import requests

url = "https://api.pav.bio/v1/fda/applications/{application_key}"

headers = {"Authorization": "Bearer <token>"}

response = requests.get(url, headers=headers)

print(response.text)

const options = {method: 'GET', headers: {Authorization: 'Bearer <token>'}};

fetch('https://api.pav.bio/v1/fda/applications/{application_key}', options)
  .then(res => res.json())
  .then(res => console.log(res))
  .catch(err => console.error(err));

<?php

$curl = curl_init();

curl_setopt_array($curl, [
  CURLOPT_URL => "https://api.pav.bio/v1/fda/applications/{application_key}",
  CURLOPT_RETURNTRANSFER => true,
  CURLOPT_ENCODING => "",
  CURLOPT_MAXREDIRS => 10,
  CURLOPT_TIMEOUT => 30,
  CURLOPT_HTTP_VERSION => CURL_HTTP_VERSION_1_1,
  CURLOPT_CUSTOMREQUEST => "GET",
  CURLOPT_HTTPHEADER => [
    "Authorization: Bearer <token>"
  ],
]);

$response = curl_exec($curl);
$err = curl_error($curl);

curl_close($curl);

if ($err) {
  echo "cURL Error #:" . $err;
} else {
  echo $response;
}

package main

import (
	"fmt"
	"net/http"
	"io"
)

func main() {

	url := "https://api.pav.bio/v1/fda/applications/{application_key}"

	req, _ := http.NewRequest("GET", url, nil)

	req.Header.Add("Authorization", "Bearer <token>")

	res, _ := http.DefaultClient.Do(req)

	defer res.Body.Close()
	body, _ := io.ReadAll(res.Body)

	fmt.Println(string(body))

}

HttpResponse<String> response = Unirest.get("https://api.pav.bio/v1/fda/applications/{application_key}")
  .header("Authorization", "Bearer <token>")
  .asString();

require 'uri'
require 'net/http'

url = URI("https://api.pav.bio/v1/fda/applications/{application_key}")

http = Net::HTTP.new(url.host, url.port)
http.use_ssl = true

request = Net::HTTP::Get.new(url)
request["Authorization"] = 'Bearer <token>'

response = http.request(request)
puts response.read_body

{
  "application": {
    "record_key": "purple_book_product:761508:001",
    "record_type": "purple_book_product",
    "source": "purple_book",
    "title": "GENGLYCOS",
    "source_version": "2026-08",
    "fda_organization_name": "Regeneron Pharmaceuticals, Inc.",
    "company": {
      "company_id": 5093,
      "short_name": "regeneron",
      "name": "Regeneron Pharmaceuticals"
    },
    "application_key": "BLA:761508",
    "product_key": "BLA:761508:001",
    "designation_id": "1186826",
    "patent_number": "10022461",
    "description": "<string>",
    "document_date": "2023-12-25",
    "event_date": "2023-12-25",
    "event_date_type": "patent_expiry",
    "status": "RX",
    "source_url": "<string>",
    "details": {
      "ingredient": "SEMAGLUTIDE",
      "strength": "300MG/5ML (60MG/ML)",
      "dosage_route": "TABLET;ORAL",
      "dosage_form": "Injection",
      "route": "Intravenous",
      "therapeutic_equivalence_code": "AB1",
      "reference_listed_drug": true,
      "reference_standard": true,
      "patent_use_code": "U-4597",
      "pediatric_extension": true,
      "drug_substance_claim": true,
      "drug_product_claim": true,
      "license_type": "351(a)",
      "licensure": "Licensed",
      "license_number": "1760",
      "orphan_exclusivity_expiry": "2023-12-25",
      "reference_product_exclusivity_expiry": "2023-12-25",
      "approval_date_raw": "Approved Prior to Jan 1, 1982",
      "generic_name": "inosine pranobex",
      "designation_withdrawn_date": "2023-12-25",
      "approvals": [
        {
          "marketing_approval_date": "2023-12-25",
          "exclusivity_end_date": "2023-12-25",
          "trade_name": "Darzalex",
          "generic_name": "daratumumab",
          "approved_labeled_indication": "<string>",
          "protected_indication": "<string>"
        }
      ],
      "brand": "Baxter",
      "reason": "Mislabeling",
      "reason_description": "<string>",
      "product_types": [
        "Drugs"
      ],
      "issuing_office": "Center for Drug Evaluation and Research (CDER)",
      "fda_reference_id": "738238",
      "closeout_date": "2023-12-25",
      "application_type": "NDA",
      "products": "NUBEQA",
      "submission_count": 123,
      "latest_submission": {
        "submission_type": "SUPPL",
        "submission_number": "16",
        "status": "AP",
        "status_date": "2023-12-25",
        "submission_class": "Labeling",
        "review_priority": "PRIORITY",
        "notes": "<string>"
      },
      "letter_type": "COMPLETE RESPONSE",
      "application_numbers": [
        "NDA 218705"
      ],
      "category": "cancer",
      "current_status": "Traditional Approval Granted (12/16/2022)",
      "confirmatory_requirements": [
        {
          "requirement": "<string>",
          "projected_completion": "2023-12-25"
        }
      ],
      "center": "Center for Drug Evaluation and Research",
      "meeting_start": "2023-11-07T05:31:56Z",
      "meeting_end": "2023-11-07T05:31:56Z",
      "documents": [
        {
          "title": "<string>",
          "url": "<string>",
          "document_type": "<string>",
          "document_date": "2023-12-25"
        }
      ]
    }
  },
  "records": [
    {
      "record_key": "purple_book_product:761508:001",
      "record_type": "purple_book_product",
      "source": "purple_book",
      "title": "GENGLYCOS",
      "source_version": "2026-08",
      "fda_organization_name": "Regeneron Pharmaceuticals, Inc.",
      "company": {
        "company_id": 5093,
        "short_name": "regeneron",
        "name": "Regeneron Pharmaceuticals"
      },
      "application_key": "BLA:761508",
      "product_key": "BLA:761508:001",
      "designation_id": "1186826",
      "patent_number": "10022461",
      "description": "<string>",
      "document_date": "2023-12-25",
      "event_date": "2023-12-25",
      "event_date_type": "patent_expiry",
      "status": "RX",
      "source_url": "<string>",
      "details": {
        "ingredient": "SEMAGLUTIDE",
        "strength": "300MG/5ML (60MG/ML)",
        "dosage_route": "TABLET;ORAL",
        "dosage_form": "Injection",
        "route": "Intravenous",
        "therapeutic_equivalence_code": "AB1",
        "reference_listed_drug": true,
        "reference_standard": true,
        "patent_use_code": "U-4597",
        "pediatric_extension": true,
        "drug_substance_claim": true,
        "drug_product_claim": true,
        "license_type": "351(a)",
        "licensure": "Licensed",
        "license_number": "1760",
        "orphan_exclusivity_expiry": "2023-12-25",
        "reference_product_exclusivity_expiry": "2023-12-25",
        "approval_date_raw": "Approved Prior to Jan 1, 1982",
        "generic_name": "inosine pranobex",
        "designation_withdrawn_date": "2023-12-25",
        "approvals": [
          {
            "marketing_approval_date": "2023-12-25",
            "exclusivity_end_date": "2023-12-25",
            "trade_name": "Darzalex",
            "generic_name": "daratumumab",
            "approved_labeled_indication": "<string>",
            "protected_indication": "<string>"
          }
        ],
        "brand": "Baxter",
        "reason": "Mislabeling",
        "reason_description": "<string>",
        "product_types": [
          "Drugs"
        ],
        "issuing_office": "Center for Drug Evaluation and Research (CDER)",
        "fda_reference_id": "738238",
        "closeout_date": "2023-12-25",
        "application_type": "NDA",
        "products": "NUBEQA",
        "submission_count": 123,
        "latest_submission": {
          "submission_type": "SUPPL",
          "submission_number": "16",
          "status": "AP",
          "status_date": "2023-12-25",
          "submission_class": "Labeling",
          "review_priority": "PRIORITY",
          "notes": "<string>"
        },
        "letter_type": "COMPLETE RESPONSE",
        "application_numbers": [
          "NDA 218705"
        ],
        "category": "cancer",
        "current_status": "Traditional Approval Granted (12/16/2022)",
        "confirmatory_requirements": [
          {
            "requirement": "<string>",
            "projected_completion": "2023-12-25"
          }
        ],
        "center": "Center for Drug Evaluation and Research",
        "meeting_start": "2023-11-07T05:31:56Z",
        "meeting_end": "2023-11-07T05:31:56Z",
        "documents": [
          {
            "title": "<string>",
            "url": "<string>",
            "document_type": "<string>",
            "document_date": "2023-12-25"
          }
        ]
      }
    }
  ],
  "submissions": [
    {
      "submission_type": "SUPPL",
      "submission_number": "16",
      "status": "AP",
      "status_date": "2023-12-25",
      "submission_class": "Labeling",
      "review_priority": "PRIORITY",
      "notes": "<string>"
    }
  ]
}

{
  "error": {
    "code": "not_found",
    "message": "program 999999 not found",
    "request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
  }
}

{
  "error": {
    "code": "not_found",
    "message": "program 999999 not found",
    "request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
  }
}

{
  "error": {
    "code": "not_found",
    "message": "program 999999 not found",
    "request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
  }
}

{
  "error": {
    "code": "not_found",
    "message": "program 999999 not found",
    "request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
  }
}